BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 28734844)

  • 1. Toll-like receptor 3 blockade in rhinovirus-induced experimental asthma exacerbations: A randomized controlled study.
    Silkoff PE; Flavin S; Gordon R; Loza MJ; Sterk PJ; Lutter R; Diamant Z; Turner RB; Lipworth BJ; Proud D; Singh D; Eich A; Backer V; Gern JE; Herzmann C; Halperin SA; Mensinga TT; Del Vecchio AM; Branigan P; San Mateo L; Baribaud F; Barnathan ES; Johnston SL
    J Allergy Clin Immunol; 2018 Apr; 141(4):1220-1230. PubMed ID: 28734844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Understanding the asthmatic response to an experimental rhinovirus infection: Exploring the effects of blocking IgE.
    Heymann PW; Platts-Mills TAE; Woodfolk JA; Borish L; Murphy DD; Carper HT; Conaway MR; Steinke JW; Muehling L; Gerald Teague W; Kennedy JL; Irani AM; McGraw MD; Early SV; Wheatley LM; Adams AP; Turner RB
    J Allergy Clin Immunol; 2020 Sep; 146(3):545-554. PubMed ID: 32018030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experimental rhinovirus challenges in adults with mild asthma: response to infection in relation to IgE.
    Zambrano JC; Carper HT; Rakes GP; Patrie J; Murphy DD; Platts-Mills TA; Hayden FG; Gwaltney JM; Hatley TK; Owens AM; Heymann PW
    J Allergy Clin Immunol; 2003 May; 111(5):1008-16. PubMed ID: 12743565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lower airway rhinovirus burden and the seasonal risk of asthma exacerbation.
    Denlinger LC; Sorkness RL; Lee WM; Evans MD; Wolff MJ; Mathur SK; Crisafi GM; Gaworski KL; Pappas TE; Vrtis RF; Kelly EA; Gern JE; Jarjour NN
    Am J Respir Crit Care Med; 2011 Nov; 184(9):1007-14. PubMed ID: 21816938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bronchial mucosal IFN-α/β and pattern recognition receptor expression in patients with experimental rhinovirus-induced asthma exacerbations.
    Zhu J; Message SD; Mallia P; Kebadze T; Contoli M; Ward CK; Barnathan ES; Mascelli MA; Kon OM; Papi A; Stanciu LA; Edwards MR; Jeffery PK; Johnston SL
    J Allergy Clin Immunol; 2019 Jan; 143(1):114-125.e4. PubMed ID: 29698627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Similar colds in subjects with allergic asthma and nonatopic subjects after inoculation with rhinovirus-16.
    DeMore JP; Weisshaar EH; Vrtis RF; Swenson CA; Evans MD; Morin A; Hazel E; Bork JA; Kakumanu S; Sorkness R; Busse WW; Gern JE
    J Allergy Clin Immunol; 2009 Aug; 124(2):245-52, 252.e1-3. PubMed ID: 19596142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rhinoviruses significantly affect day-to-day respiratory symptoms of children with asthma.
    Tovey ER; Stelzer-Braid S; Toelle BG; Oliver BG; Reddel HK; Willenborg CM; Belessis Y; Garden FL; Jaffe A; Strachan R; Eyles D; Rawlinson WD; Marks GB
    J Allergy Clin Immunol; 2015 Mar; 135(3):663-9.e12. PubMed ID: 25476729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of rhinovirus antibody titers in children with asthma exacerbations and species-specific rhinovirus infection.
    Iwasaki J; Smith WA; Khoo SK; Bizzintino J; Zhang G; Cox DW; Laing IA; Le Souëf PN; Thomas WR; Hales BJ
    J Allergy Clin Immunol; 2014 Jul; 134(1):25-32. PubMed ID: 24767874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prednisolone for the first rhinovirus-induced wheezing and 4-year asthma risk: A randomized trial.
    Koistinen A; Lukkarinen M; Turunen R; Vuorinen T; Vahlberg T; Camargo CA; Gern J; Ruuskanen O; Jartti T
    Pediatr Allergy Immunol; 2017 Sep; 28(6):557-563. PubMed ID: 28660720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. No exacerbation but impaired anti-viral mechanisms in a rhinovirus-chronic allergic asthma mouse model.
    Rochlitzer S; Hoymann HG; Müller M; Braun A;
    Clin Sci (Lond); 2014 Jan; 126(1):55-65. PubMed ID: 23822145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-IL-5 in Mild Asthma Alters Rhinovirus-induced Macrophage, B-Cell, and Neutrophil Responses (MATERIAL). A Placebo-controlled, Double-Blind Study.
    Sabogal Piñeros YS; Bal SM; van de Pol MA; Dierdorp BS; Dekker T; Dijkhuis A; Brinkman P; van der Sluijs KF; Zwinderman AH; Majoor CJ; Bonta PI; Ravanetti L; Sterk PJ; Lutter R
    Am J Respir Crit Care Med; 2019 Feb; 199(4):508-517. PubMed ID: 30192638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulmonary Innate Lymphoid Cell Responses during Rhinovirus-induced Asthma Exacerbations
    Dhariwal J; Cameron A; Wong E; Paulsen M; Trujillo-Torralbo MB; Del Rosario A; Bakhsoliani E; Kebadze T; Almond M; Farne H; Gogsadze L; Aniscenko J; Rana BMJ; Hansel TT; Jackson DJ; Kon OM; Edwards MR; Solari R; Cousins DJ; Walton RP; Johnston SL;
    Am J Respir Crit Care Med; 2021 Dec; 204(11):1259-1273. PubMed ID: 34469272
    [No Abstract]   [Full Text] [Related]  

  • 13. Exogenous IFN-β has antiviral and anti-inflammatory properties in primary bronchial epithelial cells from asthmatic subjects exposed to rhinovirus.
    Cakebread JA; Xu Y; Grainge C; Kehagia V; Howarth PH; Holgate ST; Davies DE
    J Allergy Clin Immunol; 2011 May; 127(5):1148-54.e9. PubMed ID: 21329968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiological analysis and follow-up of human rhinovirus infection in children with asthma exacerbation.
    Zheng SY; Wang LL; Ren L; Luo J; Liao W; Liu EM
    J Med Virol; 2018 Feb; 90(2):219-228. PubMed ID: 28500687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rhinovirus induction of fractalkine (CX3CL1) in airway and peripheral blood mononuclear cells in asthma.
    Upton N; Jackson DJ; Nikonova AA; Hingley-Wilson S; Khaitov M; Del Rosario A; Traub S; Trujillo-Torralbo MB; Habibi M; Elkin SL; Kon OM; Edwards MR; Mallia P; Footitt J; Macintyre J; Stanciu LA; Johnston SL; Sykes A
    PLoS One; 2017; 12(8):e0183864. PubMed ID: 28859129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation and Function of Interferon-Lambda (IFNλ) and Its Receptor in Asthma.
    Krammer S; Sicorschi Gutu C; Grund JC; Chiriac MT; Zirlik S; Finotto S
    Front Immunol; 2021; 12():731807. PubMed ID: 34899691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A mechanistic role for type III IFN-λ1 in asthma exacerbations mediated by human rhinoviruses.
    Miller EK; Hernandez JZ; Wimmenauer V; Shepherd BE; Hijano D; Libster R; Serra ME; Bhat N; Batalle JP; Mohamed Y; Reynaldi A; Rodriguez A; Otello M; Pisapia N; Bugna J; Bellabarba M; Kraft D; Coviello S; Ferolla FM; Chen A; London SJ; Siberry GK; Williams JV; Polack FP
    Am J Respir Crit Care Med; 2012 Mar; 185(5):508-16. PubMed ID: 22135341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased nuclear suppressor of cytokine signaling 1 in asthmatic bronchial epithelium suppresses rhinovirus induction of innate interferons.
    Gielen V; Sykes A; Zhu J; Chan B; Macintyre J; Regamey N; Kieninger E; Gupta A; Shoemark A; Bossley C; Davies J; Saglani S; Walker P; Nicholson SE; Dalpke AH; Kon OM; Bush A; Johnston SL; Edwards MR
    J Allergy Clin Immunol; 2015 Jul; 136(1):177-188.e11. PubMed ID: 25630941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Asthmatic bronchial epithelial cells have a deficient innate immune response to infection with rhinovirus.
    Wark PA; Johnston SL; Bucchieri F; Powell R; Puddicombe S; Laza-Stanca V; Holgate ST; Davies DE
    J Exp Med; 2005 Mar; 201(6):937-47. PubMed ID: 15781584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro susceptibility to rhinovirus infection is greater for bronchial than for nasal airway epithelial cells in human subjects.
    Lopez-Souza N; Favoreto S; Wong H; Ward T; Yagi S; Schnurr D; Finkbeiner WE; Dolganov GM; Widdicombe JH; Boushey HA; Avila PC
    J Allergy Clin Immunol; 2009 Jun; 123(6):1384-90.e2. PubMed ID: 19428098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.